Anxiety in people has many causes, from life events to sleep, health conditions, and genes. A mouse study in iScience published online in May 2025 focuses on one part of that picture: GluK4, a building block of kainate-type glutamate receptors on basolateral amygdala cells, and how it changes signaling toward the centrolateral amygdala. When researchers brought Grik4 activity back toward usual levels only in those basolateral pyramidal cells, the paper reports that the transgenic line showed reversal of anxiety-like behavior, depression-like behavior, and social deficits. In a separate cohort of mice without the transgene, animals that had already been classified as highly anxious showed partial relief of anxiety-like behavior on the elevated plus maze after the same kind of manipulation, not a broad reversal across other domains. None of this replaces human care today, but it sketches where future lab work might aim. For context on how genes can tilt anxiety risk in people, see a gene variant linked to heightened anxiety levels. For population-level habits that remain relevant, regular exercise cuts anxiety and depression drug use in large cohort data.
Grik4 overload tilts amygdala outputs before behavior shifts
The amygdala is a hub for threat-related processing, emotional memory, and stress-linked responses. Rodent-focused reviews tie basolateral amygdala hyperexcitability under stress to anxiety-related circuit changes, though human illness always involves wider networks and context.
In the mouse model, extra Grik4 copies raise GluK4 protein and change synaptic signaling from the basolateral amygdala toward the centrolateral amygdala. Kainate receptors there act less like simple on-switches and more like tuners of glutamate release and network excitability. The iScience team reports that this imbalance accompanies anxiety-like behavior, depression-like behavior in standard rodent tests, and social approach deficits, matching the direction of earlier work they cite from the same GluK4 overexpression line.
Targeted Grik4 normalization in basolateral cells reset many test behaviors
The team used AAV-CRE-GFP to normalize Grik4 levels in basolateral amygdala pyramidal cells, with AAV-GFP as a control, delivered by stereotaxic injection under a CaMKII promoter as described in the paper.
After the postsurgical recovery window used in the study, open-field and elevated-plus-maze readouts in the overexpressing line matched the paper’s report that the intervention reversed anxiety-like behavior. The same summary states that it reversed depression-like behavior in the forced swim test and social deficits in the three-chamber assay. Electrophysiology showed miniature excitatory currents in centrolateral regular-firing GABA neurons, which had been too frequent in the transgenic animals, moving back toward control values after the manipulation, while late-firing cells still showed reduced input in some measures. The authors stress regular-firing centrolateral neurons as an important stage in this pathway.
Naturally timid mice improved less than the engineered line
A separate experiment used 21 wild-type Grik4-floxed mice without the transgenic overexpression. Open-field clustering split them into “highly anxious” and “non-anxious” groups. After basolateral injections, non-anxious animals showed little change, but highly anxious animals showed only partial relief of anxiety-like behavior on the elevated plus maze after GluK4 knockdown, in the authors’ wording. That narrow finding matters when headlines imply anxiety vanishes in every mouse.
Spanish institutional communications summarized the project as identifying neuron groups that help regulate anxiety and social symptoms, aligned with the paper’s emphasis on circuit balance rather than a universal cure. The Science et vie magazine article states that signs of anxiety fully disappeared in mice. That wording suggests a complete cure and overgeneralizes the finding, especially next to the partial anxiety relief the primary paper reports for spontaneously anxious, non-transgenic mice.
Object recognition stayed impaired, a clue about specificity
Even after anxiety- and social-behavior measures improved in the transgenic rescue, novel-object recognition stayed poor compared with controls. The persistence of that impairment suggests the targeted rescue did not correct all circuits involved in this kind of cognition. The paper also notes that recognition memory draws heavily on hippocampus, cortex, and thalamus, where Grik4 in their model would still be high.
That limit still supports a practical boundary: a focused change in one amygdala subregion was enough to shift several affective readouts in this engineered line, but it did not fix every cognitive measure tied to widespread GluK4 excess.
Why human anxiety care still follows older paths today
Virally delivered Cre in the amygdala is not a clinical option. The study is explicitly preclinical. It tests an idea: in this model, adjusting GluK4 signaling from basolateral pyramidal cells onto centrolateral regular-firing neurons can change several behavioral readouts. Drug developers might someday seek medicines that influence similar chemistry in safer, whole-body dosing forms, but that would take years of human-focused work.
If you live with anxiety, mainstream clinical guidance on anxiety disorders still centers on psychotherapies with trial support, medications when a clinician finds them appropriate, sleep and exercise patterns, and social connection. Touch-based supports can matter too; large reviews find touch interventions ease pain, anxiety, and depression symptoms on average. This study helps map one brain circuit in mice. It does not show a treatment for people.
Sources and related information
Cell Press – Central role of regular firing neurons of centrolateral amygdala in affective behaviors – 2025
The peer-reviewed iScience article supplies the main quantitative and mechanistic claims used here about Grik4 normalization in basolateral amygdala pyramidal neurons, the behavioral battery, and the electrophysiology in mice, including partial relief of anxiety-like behavior on the elevated plus maze in highly anxious non-transgenic animals and the intact object recognition deficit after rescue. The PubMed entry for this paper lists online publication 13 May 2025 and the print issue as Volume 28, Issue 6 (20 June 2025).
CSIC – Identifican un grupo de neuronas implicado en la regulación de la ansiedad y los trastornos sociales – 2025
The CSIC institutional news item confirms the institutional origin of the work and restates the public-health framing that certain amygdala neuron groups help regulate anxiety-like and social symptoms in the reported mouse experiments.
Science et vie – Un simple rééquilibrage neuronal suffit à faire disparaître l’anxiété, révèle une étude sur des souris – 2025
The Science et vie magazine article is a readable French-language summary for the public. It claims anxiety signs fully disappeared in mice, which overstates how far the finding generalizes compared with the primary paper’s partial anxiety relief in spontaneously anxious non-transgenic mice.
